Login / Signup

Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.

Leonie Maria FrommertAmanthi Nadira Arumahandi de SilvaJan ZernickeVeronika ScholzTanja BraunLara Maria JeworowskiTatjana SchwarzPinkus Tober-LauAlexander Ten HagenElisa HabermannFlorian KurthLeif-Erik SanderVictor Max CormanGerd-Rüdiger R BurmesterRobert BiesenFredrik Nils AlbachJens Klotsche
Published in: RMD open (2023)
Certain immunosuppressive therapies are associated with lower antibody responses after vaccination. Additional factors such as vaccine type, age and vaccination interval should be taken into account. We recommend antibody testing in at-risk patients with AIRD and emphasise the importance of booster vaccinations in these patients.
Keyphrases
  • end stage renal disease
  • coronavirus disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • sars cov
  • rheumatoid arthritis
  • prognostic factors
  • stem cells
  • patient reported